Latin America Dry Eye Syndrome Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2023-28
                     Latin America Dry Eye 
Syndrome Market 
Research and Forecast 
Report 2023-2028
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Accord ing  to  the  la t es t  repo r t  by  IMARC Group ,  t i t l ed  " Lat i n  Amer ica  Dry  Eye 
Syndrome Market :  Indust ry  T rends ,  Share ,  S i ze ,  Growth ,  Opportun i ty  and  
Forecast  2023-2028 ,"  t he  La t in  Amer ica  d ry  eye  syndrome marke t  s i ze  reached 
US$  248. 4  M i l l i on  i n  2022.
Report Dry  eye  syndrom e re fe rs  t o  a  med ica l  cond i t i on  t ha t  occurs  due  t o  a  l ack  o f  
adequat e  lubr i ca t ion  on  the  sur face  o f  t he  eyes .  I t  can  be  caused due  t o  mu l t ip l e  
f ac t o rs ,  such  as  v i t am in  de f i c iency ,  p ro longed  sc reen  usage ,  lase r  surge r i es ,  
Highlight and au to immune  d iseases ,  menopause  and a l le rg ies .  
I t  i s  a  cond i t i on  t ha t  i s  charac te r i zed  by  mu l t ip le  symptoms ,  inc lud ing  d iscomfo r t ,  
Description burn ing  o r  s t ing ing  sensa t ion ,  r edness ,  b lu r ry  v i s ion ,  and  sens i t i v i t y  t o  l i gh t  
ach ing .  Add i t i ona l l y ,  i t  a l so  causes  d i s t u rbance  o f  t he  lac r ima l  f unc t iona l  un i t ,  
i nc lud ing  lac r ima l  g lands ,  ocu la r  su r face  and l i ds .  I t  can  genera l l y  be  t r ea ted  by  
eye  d rops ,  lac r ima l  p lugs ,  med ica t ions  and su rge r ies .
Request  fo r  a  PDF  sample  o f  th i s  repor t :  
ht tps : / / www. imarcgroup .com/ la t in -amer ica-dry -eye -syndrome-marke t / reques t samp l
e
Report Description
L a t i n  A m e r i c a  D r y  E y e  S y n d r o m e  M a r k e t  T r e n d s :
T h e  m a r k e t  i n  L a t i n  A m e r i c a  i s  p r i m a r i l y  d r i v e n  b y  t h e  c h a n g i n g  l i f e s t y l e  p a t t e r n s  o f  t h e  ma s s e s .  T h i s  c a n  b e  a t t r i b u t e d  t o  t h e  
i n c r e a s i n g  u t i l i z a t i o n  o f  s m a r tp h o n e s  a n d  l a p to p s  b y  s t u d e n t s  a n d  w o r k i n g  p r o f e s s i o n a l s .  M o r e o v e r ,  t h e  r i s i n g  p r e v a l e n c e  o f  
c h r o n i c  o c u l a r  d i s e a s e s  a mo n g  i n d i v i d u a l s  i s  p r o v i d i n g  a  t h r u s t  t o  t h e  m a r k e t .  C o u p l e d  w i t h  t h e  g r o w i n g  g e r i a t r i c  p o p u l a t i o n  t h a t  
i s  s u s c e p t i b l e  t o  v a r i o u s  m e d i c a l  i l l n e s s e s ,  t h i s  i s  i m p a c t i n g  t h e  m a r k e t  g r o w t h  f a v o r a b l y .  A l o n g  w i t h  t h i s ,  t h e  i n c r e a s i n g  a d o p t i o n  
o f  c o n t a c t  l e n s e s  a n d  i m p r o p e r  d i e t  r o u t i n e s  o f  t h e  m a s s e s  i s  a l s o  c o n t r i b u t i n g  t o  t h e  r i s i n g  o c c u r r e n c e s  o f  d r y  e y e  s y n d r o m e .  
A p a r t  f r o m  th i s ,  h e a v y  i n v e s tm e n t s  b y  p r i v a te  a n d  p u b l i c  a g e n c i e s  f o r  i m p r o v i n g  t h e  o v e r a l l  h e a l t h c a r e  i n f r a s t r u c t u r e  a r e  f u r t h e r  
c a t a l y z i n g  t h e  m a r k e t .  I n  a d d i t i o n  t o  t h i s ,  t h e  i n c r e a s i n g  a w a r e n e s s  r e g a r d i n g  t h e  a v a i l a b i l i t y  o f  v a r i o u s  t r e a t m e n t s  f o r  d r y  e y e  
s y n d r o m e  a n d  t h e  i n f l a t i n g  d i s p o s a b l e  i n c o me  l e v e l s  o f  i n d i v i d u a l s  a r e  c r e a t i n g  a  p o s i t i v e  m a r k e t  o u t l o o k .  O t h e r  f a c to r s ,  i n c l u d i n g  
c o n t i n u a l  t e c h n o l o g i c a l  a d v a n c e m e n t s  i n  t h e  h e a l t h c a r e  i n d u s t r y ,  t h e  g r o w i n g  n u m b e r  o f  c l i n i c a l  t r i a l s  a n d  e x te n s i v e  r e s e a r c h  a n d  
d e v e l o p m e n t  ( R & D )  a c t i v i t i e s ,  a r e  a l s o  p o s i t i v e l y  i n f l u e n c i n g  t h e  ma r k e t  a c r o s s  L a t i n  A m e r i c a .
L o o k in g  f o r w a r d ,  t h e  m a r k e t  i s  a n t i c ip a t e d  t o  r e a c h  a  v a lu e  o f  U S $  3 5 6 . 3  M i l l i o n  b y  2 0 2 8 ,  e x h i b i t i n g  a  C A G R  o f  5 . 9 %  d u r in g  
2 0 2 3 - 2 0 2 8 .
V ie w  R e p o r t  T O C ,  F i g u r e s  a n d  T a b l e s :  h t t p s : / / w w w . i m a r c g r o u p . c o m / l a t in - a m e r ic a - d r y - e y e - s y n d r o m e - m a r k e t
Breakup by Disease Type:
• Evaporative
• Aqueous
 
Breakup by Drug Type:
• Anti- infl ammatory Drugs
•
Report Lubricant Eye Drops
• Autologous Serum Eye Drops
Segmentation
Breakup by Product:
• Liquid Drops
• Gel
• Liquid Wipes
• Eye Ointment
• Others
Breakup by Distribution Channel:
• Hospital  Pharmacies
• Retai l  Pharmacies
• Online Pharmacies
Breakup by Country:
Report 
• Brazi l
Segmentation • Mexico
• Argentina
• Colombia
• Chi le
• Peru
• Others
What was the size of the Latin America dry eye 
syndrome market in 2022?
What is the expected growth rate of the Latin 
America dry eye syndrome market during 2023-
2028?
What are the key factors driving the Latin America 
dry eye syndrome market?
Key 
What has been the impact of COVID-19 on the Latin 
Questions America dry eye syndrome market?
Answered in What is the breakup of the Latin America dry eye syndrome market based on the disease type?
the Report What is the breakup of the Latin America dry eye 
syndrome market based on the drug type?
 What is the breakup of the Latin America dry eye 
syndrome market based on the product?
What is the breakup of the Latin America dry eye 
syndrome market based on the distribution 
channel?
What are the key regions in the Latin America dry 
eye syndrome market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
        2 . 4 . 1     B o t t o m - U p  A p p r o a c h
Table of         2 . 4 . 2     T o p - D o w n  A p p r o a c h    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
    4 . 1     O v e r v i e w
Contents     4 . 2     K e y  I n d u s t r y  T r e n d s5     L a t i n  A m e r i c a  D r y  E y e  S y n d r o m e  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  D i s e a s e  T y p e  
    6 . 1     E v a p o r a t i v e  D r y  E y e  S y n d r o m e  
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     A q u e o u s  D r y  E y e  S y n d r o m e
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  D r u g  T y p e
    7 . 1     A n t i - i n f l a m m a t o r y  D r u g s
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
       
    7 . 2     L u b r i c a n t  E y e  D r o p s
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
    7 . 3     A u t o l o g o u s  S e r u m  E y e  D r o p s  
        7 . 3 . 1  M a r k e t  T r e n d s
        7 . 3 . 2  M a r k e t  F o r e c a s t
8    M a r k e t  B r e a k u p  b y  P r o d u c t
    8 . 1     L i q u i d  D r o p s  
        8 . 1 . 1  M a r k e t  T r e n d s
        8 . 1 . 2  M a r k e t  F o r e c a s t
Table of     8 . 2     G e l          8 . 2 . 1  M a r k e t  T r e n d s
        8 . 2 . 2  M a r k e t  F o r e c a s t
    8 . 3     L i q u i d  W i p e s  
Contents         8 . 3 . 1  M a r k e t  T r e n d s        8 . 3 . 2  M a r k e t  F o r e c a s t
    8 . 4     E y e  O i n t m e n t  
        8 . 4 . 1  M a r k e t  T r e n d s
        8 . 4 . 2  M a r k e t  F o r e c a s t
    8 . 5     O t h e r s
        8 . 5 . 1  M a r k e t  T r e n d s
        8 . 5 . 2  M a r k e t  F o r e c a s t
9    M a r k e t  B r e a k u p  b y  D i s t r i b u t i o n  C h a n n e l
    9 . 1     H o s p i t a l  P h a r m a c i e s
        9 . 1 . 1  M a r k e t  T r e n d s
        9 . 1 . 2  M a r k e t  F o r e c a s t
    9 . 2     R e t a i l  P h a r m a c i e s
        9 . 2 . 1  M a r k e t  T r e n d s
        9 . 2 . 2  M a r k e t  F o r e c a s t     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
h t t p s : / / w w w. im a rcg ro u p . co m / l a t i n - a m er i ca - d r y - e y e - s y n d ro m e - m
a r ke t / t o c
Disclaimer
© 2023  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145 
E-MAIL: [email protected]